Use this url to cite publication: https://hdl.handle.net/20.500.12512/81895
Efficacy and safety of Teverelix, a new Gonadotrophin releasing hormone antagonist in patients with advanced prostate cancer. Results from a phase 2 multicentre, open-label, pilot study investigating an initial intramuscular loading dose regimen of teverelix
Type of publication
Tezės Web of Science duomenų bazėje / Theses in Web of Science database (T1a1)
Author(s)
| Author | Affiliation |
|---|---|
Maclean, C | |
Title
Efficacy and safety of Teverelix, a new Gonadotrophin releasing hormone antagonist in patients with advanced prostate cancer. Results from a phase 2 multicentre, open-label, pilot study investigating an initial intramuscular loading dose regimen of teverelix
C. Maclean, A. Ulys, F. Jankevičius, D. Kaniušas, J. Drewe, F. Larsen
Extent
p. 251.
Is part of
European urology. Supplements. Amsterdam : Elsevier Science., 2006, vol. 5, iss. 2, April.
Version
Originalus / Original
Series/Report no.
Oral Communications & Discussed Posters
Type of document
type::text::conference output::conference proceedings::conference paper
ISSN (of the container)
1569-9056
Other Identifier(s)
(LSMU ALMA)990000677480107106
Coverage Spatial
Jungtinė Karalystė / United Kingdom of Great Britain and Northern Ireland (GB)
Language
Anglų / English (en)